Science Café – Therapeutic Anti-Cancer Potential of a Novel KDM5C Inhibitor

Science Café – Therapeutic Anti-Cancer Potential of a Novel KDM5C Inhibitor

Categories: Lectures and Seminars | Intended for

Wednesday, August 05, 2020

1:30 PM - 2:30 PM | Add to calendar

Location Details

Virtual Event Via Zoom Webinar

Contact Information

Office of the Dean of Science, 613-520-4388, odscience@carleton.ca

Cost

Free

About this Event

Host Organization: Office of the Dean of Science
More Information: Please click here for additional details.

Guest Speaker: Kyle Biggar, Assistant Professor, Institute of Biochemistry

Cancer is caused by unregulated cellular growth, leading to catastrophic consequences for the tissues and organs in which these cells uncontrollably multiply. Research over the past 15+ years has revealed that gene mutation and expression changes underlie the onset, progression, and therapeutic resistance of cancer. The DNA encoding these genes are packaged into a structure called chromatin, and chemical modifications to specific proteins within this structure impart regulatory information impacting the gene expression alterations that underlie cancer. These chemical modifications are termed ‘epigenetic’ as they represent a layer of regulation that is over-and-above (‘epi’) the genetic information encoded by the DNA. Importantly, mutations in regulators that control these epigenetic modification are major drivers of cancer. One of these regulators with a well-documented role in driving cancer is a lysine demethylase enzyme called KDM5C. However, the mechanism through which KDM5C regulates tumor growth and drug resistance remain unclear at this time. To help study KDM5C as a therapeutic target for cancer treatment, the Biggar lab has already developed a promising new inhibitor of this enzyme. To date, we have used this cell-active inhibitor to understand KDM5C biology in unprecedented ways. What is especially promising is that cancer cells treated with this inhibitor have displayed increased sensitivity to chemotherapy. By exploiting the strengths of both our computational, biochemical, cellular, and animal-based experimental systems, we are currently working to further develop our inhibitor to identify and functionally characterize the cancer-promoting role of KDM5C and its potential as a therapeutic cancer target. This talk will focus on the development of peptide-based drugs and their potential as a growing class of cancer therapeutics.

About the Science Café

Come and virtually join us for a lively discussion around a scientific issue of the day. Be prepared to be informed, engaged and even amused, as our professors share their scientific discoveries with you. All are welcome. For more information, please contact the Faculty of Science by email at odscience@carleton.ca

Attending via Zoom Webinar

Register and detailed instructions will be emailed to you prior to the online event.